21.03.2017 • NewsDede Willamspropanolconstruction

Oxea Builds new Propanol Unit in Texas

CEO Salim Al Huthaili,said the capacity addition is another example of Oxea’s...
CEO Salim Al Huthaili,said the capacity addition is another example of Oxea’s commitment as a reliable supplier. He said the company is significantly investing in its production platforms and continuously seeking opportunities for differentiation. “We aim for further expansion of our portfolio and growth in volumes over the coming period,” he added.

US petrochemical producer Oxea has begun construction on a new plant at Bay City, Texas, for 100,000 t/y of propanol and 40,000 t/year of propionaldehyde. Purnendu Rai, executive vice president, global sales and oxo-intermediates at the Dallas, Texas-based company, said the project reflects a long-term selective growth strategy and helps to reinforce Oxea’s strong position as the largest producer of propanol worldwide.

CEO Salim Al Huthaili,said the capacity addition is another example of Oxea’s commitment as a reliable supplier. He said the company is significantly investing in its production platforms and continuously seeking opportunities for differentiation. “We aim for further expansion of our portfolio and growth in volumes over the coming period,” he added.

The construction management contract for the Propanol 2 project has been awarded to US-based Jacobs Engineering Group, which will deliver pre-construction planning and construction management services.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.